Skip to content

Patents

AdaptDx Pro

U.S. Patent No. 7,494,222
U.S. Patent No. 7,798,646
U.S. Patent No. 9,050,021
U.S. Patent No. 9,572,485
U.S. Patent No. 9,504,379
U.S. Patent No. 9,730,579
U.S. Patent No. 8,795,191
U.S. Patent No. 10,667,683
Canadian Patent No. 2,536,825
Canadian Patent No. 2,689,971
Canadian Patent No. 2,863,230
European Patent No. 1,662,979
European Patent No. 2,412,303
European Patent No. 2,412,304
Japanese Patent No. 4,979,381
Australian Patent No. 2008216683
Australian Patent No. 2014208236
Canadian Patent No. 2,677,521
Canadian Patent No. 5,560,044
Japanese Patent No. 5,777,753
European Patent No. 2120677
Australian Design Registration No. 202011756
Australian Design Registration No. 202011757
Australian Design Registration No. 202013813
Australian Design Registration No. 202011761
Australian Design Registration No. 202011764
Australian Design Registration No. 202011770
Chinese Design Registration No. 2020301014116
Chinese Design Registration No. 2020301012905
Other Patents Pending

AdaptDx

U.S. Patent No. 7,494,222
U.S. Patent No. 7,798,646
U.S. Patent No. 9,050,021
U.S. Patent No. 9,572,485
U.S. Patent No. 9,504,379
U.S. Patent No. 9,730,579
U.S. Patent No. 8,795,191
Canadian Patent No. 2,536,825
Canadian Patent No. 2,689,971
Canadian Patent No. 2,863,230
European Patent No. 1,662,979
European Patent No. 2,412,303
European Patent No. 2,412,304
Japanese Patent No. 4,979,381
Australian Patent No. 2008216683
Australian Patent No. 2014208236
Canadian Patent No. 2,677,521
Canadian Patent No. 5,560,044
Japanese Patent No. 5,777,753
European Patent No. 2120677
Other Patents Pending

Registered Trademarks in the United States

AdaptDx
MacuLogix
The AMD Experts
AMD Center of Excellence
AMD Excellence Program
AMD Academy
Other U.S. and International trademarks pending

How AdaptDx Helps Detect AMD

AMD Detection with AdaptDx

The AdaptDx testing tool from MacuLogix offers you the chance to diagnosis AMD in patients before vision loss occurs.

AMD Research

Compelling research proves AdaptDx reveals the earliest signs of AMD.